Dr. Dmitriy Nevelev, MD
NPI: 1467808865
Total Payments
$30,107
2024 Payments
$29,328
Companies
7
Transactions
26
Medicare Patients
5,104
Medicare Billing
$290,062
Payment Breakdown by Category
Research$28,630 (95.1%)
Food & Beverage$1,477 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $28,630 | 1 | 95.1% |
| Food and Beverage | $1,477 | 25 | 4.9% |
Payments by Type
Research
$28,630
1 transactions
General
$1,477
25 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $28,630 | 1 | $0 (2024) |
| Medtronic, Inc. | $656.63 | 8 | $0 (2024) |
| Edwards Lifesciences Corporation | $322.99 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $221.63 | 11 | $0 (2024) |
| Abbott Laboratories | $151.55 | 1 | $0 (2023) |
| Amgen Inc. | $102.52 | 1 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $21.85 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,328 | 15 | Eli Lilly and Company ($28,630) |
| 2023 | $549.65 | 9 | Medtronic, Inc. ($176.12) |
| 2022 | $229.76 | 2 | Medtronic, Inc. ($229.76) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Eli Lilly and Company | — | — | Cash or cash equivalent | $28,630.00 | Research |
| Study: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND THE DECLINE IN KIDNEY FUNCTION IN PARTICIPANTS WITH BODY MASS INDEX GREATER THAN 27 KG M2 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OR CHRONIC KIDNEY DISEASE | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $117.21 | General |
| Category: Transcatheter Valve Systems | ||||||
| 06/27/2024 | Edwards Lifesciences Corporation | INSPIRIS RESILIA AORTIC VALVE (Device) | Food and Beverage | In-kind items and services | $169.02 | General |
| Category: Pericardial Heart Valves | ||||||
| 06/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/06/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/06/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $115.86 | General |
| Category: Renal Denervation System | ||||||
| 03/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/05/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $102.52 | General |
| 02/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2023 | Edwards Lifesciences Corporation | INSPIRIS RESILIA AORTIC VALVE (Device) | Food and Beverage | In-kind items and services | $144.79 | General |
| Category: Pericardial Heart Valves | ||||||
| 08/25/2023 | Edwards Lifesciences Corporation | INSPIRIS RESILIA AORTIC VALVE (Device) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: Pericardial Heart Valves | ||||||
| 08/22/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $151.55 | General |
| Category: Vascular | ||||||
| 07/26/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $70.42 | General |
| Category: Transcatheter Valve Systems | ||||||
| 07/26/2023 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $70.41 | General |
| Category: Stents | ||||||
| 07/19/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/15/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $35.29 | General |
| Category: Transcatheter Valve Systems | ||||||
| 08/04/2022 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $104.76 | General |
| Category: Stents | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND THE DECLINE IN KIDNEY FUNCTION IN PARTICIPANTS WITH BODY MASS INDEX GREATER THAN 27 KG M2 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OR CHRONIC KIDNEY DISEASE | Eli Lilly and Company | $28,630 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,674 | 5,066 | $1.6M | $220,472 |
| 2022 | 12 | 1,430 | 1,647 | $453,874 | $69,591 |
Total Patients
5,104
Total Services
6,713
Medicare Billing
$290,062
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 326 | 618 | $425,802 | $66,959 | 15.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 283 | 298 | $445,569 | $51,069 | 11.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 365 | 377 | $137,892 | $22,279 | 16.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,640 | 2,320 | $102,080 | $16,162 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $77,945 | $11,889 | 15.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 392 | 718 | $99,802 | $9,141 | 9.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 64 | $29,440 | $6,952 | 23.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 31 | $41,447 | $6,099 | 14.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 68 | 68 | $27,332 | $4,491 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 55 | $27,170 | $4,103 | 15.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 54 | $17,388 | $3,757 | 21.6% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 15 | 16 | $24,592 | $3,464 | 14.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 33 | 33 | $18,650 | $3,078 | 16.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 42 | 42 | $14,196 | $2,886 | 20.3% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 17 | 17 | $28,203 | $1,689 | 6.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $6,655 | $1,315 | 19.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 12 | $4,860 | $1,006 | 20.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 76 | 76 | $5,928 | $922.24 | 15.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 14 | 15 | $7,485 | $714.45 | 9.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 13 | 13 | $3,237 | $620.52 | 19.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 31 | 31 | $3,069 | $479.26 | 15.6% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 19 | 19 | $2,280 | $373.14 | 16.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 14 | 15 | $8,910 | $333.75 | 3.7% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 30 | 30 | $2,490 | $324.44 | 13.0% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 14 | 14 | $1,848 | $273.36 | 14.8% |
About Dr. Dmitriy Nevelev, MD
Dr. Dmitriy Nevelev, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2016. The National Provider Identifier (NPI) number assigned to this provider is 1467808865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dmitriy Nevelev, MD has received a total of $30,107 in payments from pharmaceutical and medical device companies, with $29,328 received in 2024. These payments were reported across 26 transactions from 7 companies. The most common payment nature is "" ($28,630).
As a Medicare-enrolled provider, Nevelev has provided services to 5,104 Medicare beneficiaries, totaling 6,713 services with total Medicare billing of $290,062. Data is available for 2 years (2022–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Cardiovascular Disease
- Location Bronx, NY
- Active Since 05/04/2016
- Last Updated 03/25/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1467808865
Products in Payments
- INSPIRIS RESILIA AORTIC VALVE (Device) $322.99
- RESOLUTE ONYX (Device) $229.76
- COREVALVE EVOLUT R (Device) $222.92
- LEQVIO (Drug) $221.63
- MITRACLIP (Device) $151.55
- SYMPLICITY G3 (Device) $115.86
- ONYX FRONTIER (Device) $70.41
- LifeVest (Device) $21.85
- FFRANGIO (Device) $17.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Bronx
Dr. David Altschul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $394,687
Student in an Organized Health Care Education/Training Program $394,687
Edvard Skripochnik, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $127,559
Student in an Organized Health Care Education/Training Program $127,559
Dr. Cynthia Armand
Student in an Organized Health Care Education/Training Program — Payments: $68,024
Student in an Organized Health Care Education/Training Program $68,024
Dr. Eric Woods, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,336
Student in an Organized Health Care Education/Training Program $40,336
Ms. Kavita Gupta, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $31,772
Student in an Organized Health Care Education/Training Program $31,772
Sung Lee, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $23,520
Student in an Organized Health Care Education/Training Program $23,520